Essa Pharma Stock Buy Hold or Sell Recommendation
| EPIX Stock | USD 1.75 0.04 2.23% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding ESSA Pharma is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell ESSA Pharma given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for ESSA Pharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out ESSA Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide. In addition, we conduct extensive research on individual companies such as ESSA and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards ESSA Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
ESSA |
Execute ESSA Pharma Buy or Sell Advice
The ESSA recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ESSA Pharma. Macroaxis does not own or have any residual interests in ESSA Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ESSA Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ESSA Pharma Trading Alerts and Improvement Suggestions
| ESSA Pharma generated a negative expected return over the last 90 days | |
| ESSA Pharma has high historical volatility and very poor performance | |
| ESSA Pharma may become a speculative penny stock | |
| Net Loss for the year was (26.58 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ESSA Pharma currently holds about 174.6 M in cash with (19.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ESSA Pharma has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from accesswire.com: EPIX ACTIVE INVESTIGATION Contact Levi Korsinsky if you lost money on your ESSA Pharma Inc. investment |
ESSA Pharma Returns Distribution Density
The distribution of ESSA Pharma's historical returns is an attempt to chart the uncertainty of ESSA Pharma's future price movements. The chart of the probability distribution of ESSA Pharma daily returns describes the distribution of returns around its average expected value. We use ESSA Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ESSA Pharma returns is essential to provide solid investment advice for ESSA Pharma.
| Mean Return | -0.64 | Value At Risk | -6.45 | Potential Upside | 9.30 | Standard Deviation | 10.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ESSA Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ESSA Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as ESSA Pharma, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading ESSA Pharma back and forth among themselves.
| Shares | Cibc World Markets Inc. | 2024-09-30 | 73.6 K | D. E. Shaw & Co Lp | 2024-09-30 | 63 K | American Century Companies Inc | 2024-09-30 | 46.7 K | Bnp Paribas Arbitrage, Sa | 2024-09-30 | 44.5 K | Kennedy Capital Management Inc | 2024-09-30 | 41.1 K | Royal Bank Of Canada | 2024-09-30 | 40.8 K | Citadel Advisors Llc | 2024-09-30 | 28.5 K | Group One Trading, Lp | 2024-09-30 | 27.8 K | Geode Capital Management, Llc | 2024-09-30 | 26.9 K | Bvf Inc | 2024-09-30 | 8.7 M | Bellevue Group Ag | 2024-09-30 | 7.9 M |
ESSA Pharma Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (21.7M) | (35.0M) | (52.3M) | (3.5M) | (3.2M) | (3.3M) | |
| Change In Cash | 3.0M | 81.5M | (80.7M) | (23.4M) | (21.0M) | (20.0M) | |
| Net Borrowings | (2.8M) | (4.0M) | (100.3K) | (134.0K) | (120.6K) | (114.6K) | |
| Depreciation | 110.3K | 109.5K | 121.8K | 118.5K | 136.3K | 68.8K | |
| Net Income | (23.4M) | (36.8M) | (35.1M) | (26.6M) | (23.9M) | (25.1M) | |
| End Period Cash Flow | 56.3M | 137.8M | 57.1M | 33.7M | 38.8M | 37.2M | |
| Change To Netincome | 1.8M | 7.6M | 9.3M | 7.1M | 8.1M | 8.5M | |
| Free Cash Flow | (17.0M) | (25.4M) | (28.7M) | (19.8M) | (17.8M) | (18.7M) | |
| Other Non Cash Items | 224.1K | (35.3K) | (830.8K) | (664.5K) | (764.2K) | (802.4K) |
ESSA Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ESSA Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ESSA Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ESSA stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.64 | |
β | Beta against Dow Jones | -0.04 | |
σ | Overall volatility | 10.37 | |
Ir | Information ratio | -0.08 |
ESSA Pharma Volatility Alert
ESSA Pharma is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ESSA Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ESSA Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ESSA Pharma Fundamentals Vs Peers
Comparing ESSA Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ESSA Pharma's direct or indirect competition across all of the common fundamentals between ESSA Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as ESSA Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ESSA Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ESSA Pharma to competition |
| Fundamentals | ESSA Pharma | Peer Average |
| Return On Equity | -0.2 | -0.31 |
| Return On Asset | -0.15 | -0.14 |
| Current Valuation | (50.9 M) | 16.62 B |
| Shares Outstanding | 44.39 M | 571.82 M |
| Shares Owned By Insiders | 2.26 % | 10.09 % |
| Shares Owned By Institutions | 81.18 % | 39.21 % |
| Number Of Shares Shorted | 726.53 K | 4.71 M |
| Price To Earning | (1.12) X | 28.72 X |
| Price To Book | 0.62 X | 9.51 X |
| EBITDA | (26.46 M) | 3.9 B |
| Net Income | (26.58 M) | 570.98 M |
| Cash And Equivalents | 174.6 M | 2.7 B |
| Cash Per Share | 3.96 X | 5.01 X |
| Total Debt | 80.33 K | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 43.43 X | 2.16 X |
| Book Value Per Share | 2.90 X | 1.93 K |
| Cash Flow From Operations | (19.78 M) | 971.22 M |
| Short Ratio | 0.36 X | 4.00 X |
| Earnings Per Share | (0.62) X | 3.12 X |
| Target Price | 13.2 | |
| Number Of Employees | 50 | 18.84 K |
| Beta | 1.84 | -0.15 |
| Market Capitalization | 79.46 M | 19.03 B |
| Total Asset | 149.12 M | 29.47 B |
| Retained Earnings | (179.46 M) | 9.33 B |
| Working Capital | 145.3 M | 1.48 B |
| Current Asset | 10.02 M | 9.34 B |
| Current Liabilities | 3.63 M | 7.9 B |
| Net Asset | 149.12 M |
Note: Acquisition by Parkinson David Ross of 350000 shares of ESSA Pharma at 9.04 subject to Rule 16b-3 [view details]
ESSA Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ESSA . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 25163.31 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 1.78 | |||
| Day Typical Price | 1.77 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.04) |
About ESSA Pharma Buy or Sell Advice
When is the right time to buy or sell ESSA Pharma? Buying financial instruments such as ESSA Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ESSA Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.